Assignee
CONVALIFE SHANGHAI CO LTD
CN·4 granted patents·4 citations·filing 2020–2022
Top patents by PatentIndex Score
4 records- 0192US11708378B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsCONVALIFE SHANGHAI CO LTD·Filed 2021·Granted Jul 25, 2023·2 cites·11 claims
- 0286US11779586B2Compounds comprising tricyclic heterocyclic compoundsCONVALIFE SHANGHAI CO LTD·Filed 2020·Granted Oct 10, 2023·2 cites·12 claims
- 0371US12257254B2Compositions comprising phosphoinositide 3-kinase inhibitors and a second antiproliferative agentCONVALIFE SHANGHAI CO LTD·Filed 2022·Granted Mar 25, 2025·0 cites·17 claims
- 0441US12551487B2PI3K inhibitor for use in the therapy of b cell lymphomaCONVALIFE SHANGHAI CO LTD·Filed 2020·Granted Feb 17, 2026·0 cites·22 claims
Join the waitlist — get patent alerts
Get an alert when CONVALIFE SHANGHAI CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →